How big is the North America Insulin Syringe Market?

The North America Insulin Syringe Market size is expected to reach USD 255.03 million in 2024 and grow at a CAGR of 1.7% to reach USD 277.47 million by 2029. Read More

What is the current North America Insulin Syringe Market size?

In 2024, the North America Insulin Syringe Market size is expected to reach USD 255.03 million. Read More

Who are the key players in North America Insulin Syringe Market?

Becton Dickinson, Cardinal Health Inc., Trividia Health Inc., Arkray Inc. and Ultimed Inc. are the major companies operating in the North America Insulin Syringe Market. Read More

What years does this North America Insulin Syringe Market cover, and what was the market size in 2023?

In 2023, the North America Insulin Syringe Market size was estimated at USD 250.69 million. The report covers the North America Insulin Syringe Market historical market size for years: 2018, 2019, 2020, 2021, 2022 and 2023. The report also forecasts the North America Insulin Syringe Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

North America Insulin Syringe Companies

This report lists the top North America Insulin Syringe companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the North America Insulin Syringe industry.